Quanterix logo
Quanterix
QTRX | NASDAQ
Chart Builder DCF Calculator
$2.84
-$0.09 (-3.07%)
At close: Nov 16, 2026, 4:00 PM ET
$2.88
+$0.04 (+1.41%)
After-hours: Nov 16, 2026, 7:30 PM ET

Quanterix Company Profile

Company profile explained

Company Profile

Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's core offerings include several innovative instruments: The HD-X instrument, which provides highly sensitive and automated multiplex protein detection. The SR-X instrument, enabling researchers to leverage Simoa detection technology for diverse uses, such as the direct detection of nucleic acids. The SP-X instrument, which utilizes Simoa planar array technology for conducting multiplex chemiluminescent immunoassays. Alongside these platforms, Quanterix also supplies crucial consumables, including assay kits and reagents. In addition to its product line, the company delivers various contract research services, encompassing sample analysis, the development of custom "homebrew" assays, and other specialized research and development projects. Quanterix's operational focus spans critical health areas like neurology, oncology, cardiology, infectious diseases, and inflammation. Its clientele within the life science research sector primarily consists of laboratories affiliated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research organizations. Sales are managed through a multifaceted approach, combining a direct sales force, dedicated support organizations, and a network of distributors or sales agents. The company was initially incorporated in 2007 as Digital Genomics, Inc., before rebranding to Quanterix Corporation in August of the same year.

Key Executives

Name Position
Everett V. Cunningham President, Chief Executive Officer & Director
Anthony Catalano Chief Operating Officer
Daniel S. Char Chief Legal Officer & Corporate Secretary
Erica Bell Chief People Officer
Jason Faessler Chief Financial Officer & Treasurer
David R. Walt Co-Founder & Chairman of Scientific Advisory Board
Joshua Young Head of Investor Relations
Michael Miller Chief Technology & Products Officer
Naren Bhat Chief Strategy Officer
William Donnelly Executive Chair

Latest SEC Filings

Date Type Title
Oct 16, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Sep 17, 2026 4 Filing
Sep 16, 2026 4 Filing
Sep 11, 2026 S-8 Filing
Sep 01, 2026 4 Filing
Aug 20, 2026 4 Filing
Aug 19, 2026 3 Filing
View All SEC Filings ➞
Quanterix
Quanterix logo
Country United States
IPO Date Dec 7, 2017
Industry Medical - Devices
Sector Healthcare
Employees 450
CEO Everett V. Cunningham

Contact Details

Building 1 Billerica, Massachusetts 01821 United States

Stock Details

Ticker Symbol QTRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001503274
CUSIP Number 74766Q101
ISIN Number US74766Q1013
SIC Code 3826

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.